Researchers probe genetic clues to tame rare inflammatory disease
NCT ID NCT06688838
Summary
This study aims to understand how well the medication tofacitinib works for people with Blau Syndrome, a rare genetic inflammatory disease. Researchers will look back at the medical records of 24 patients to see how their symptoms responded to treatment. They will also check if specific genetic features can predict who benefits most from this therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLAU SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Yikai YU
Wuhan, Hubei, 430030, China
Conditions
Explore the condition pages connected to this study.